Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.
N Engl J Med. 2015 Mar 26;372(13):1189-91. doi: 10.1056/NEJMp1500526.
N Engl J Med. 2015.
PMID: 25806913
No abstract available.
Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.
Paterniti MO, Bi Y, Rekić D, Wang Y, Karimi-Shah BA, Chowdhury BA.
Paterniti MO, et al. Among authors: karimi shah ba.
Ann Am Thorac Soc. 2017 Sep;14(9):1395-1402. doi: 10.1513/AnnalsATS.201606-458OC.
Ann Am Thorac Soc. 2017.
PMID: 28388260
Item in Clipboard
A disease progression model of longitudinal lung function decline in idiopathic pulmonary fibrosis patients.
Bi Y, Rekić D, Paterniti MO, Chen J, Marathe A, Chowdhury BA, Karimi-Shah BA, Wang Y.
Bi Y, et al. Among authors: karimi shah ba.
J Pharmacokinet Pharmacodyn. 2021 Feb;48(1):55-67. doi: 10.1007/s10928-020-09718-9. Epub 2020 Sep 19.
J Pharmacokinet Pharmacodyn. 2021.
PMID: 32949322
Item in Clipboard
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Raghu G, Ghazipura M, Fleming TR, Aronson KI, Behr J, Brown KK, Flaherty KR, Kazerooni EA, Maher TM, Richeldi L, Lasky JA, Swigris JJ, Busch R, Garrard L, Ahn DH, Li J, Puthawala K, Rodal G, Seymour S, Weir N, Danoff SK, Ettinger N, Goldin J, Glassberg MK, Kawano-Dourado L, Khalil N, Lancaster L, Lynch DA, Mageto Y, Noth I, Shore JE, Wijsenbeek M, Brown R, Grogan D, Ivey D, Golinska P, Karimi-Shah B, Martinez FJ.
Raghu G, et al.
Am J Respir Crit Care Med. 2024 Mar 15;209(6):647-669. doi: 10.1164/rccm.202312-2213SO.
Am J Respir Crit Care Med. 2024.
PMID: 38174955
Item in Clipboard
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD.
Tager AM, et al. Among authors: karimi shah ba.
Nat Med. 2008 Jan;14(1):45-54. doi: 10.1038/nm1685. Epub 2007 Dec 9.
Nat Med. 2008.
PMID: 18066075
Item in Clipboard
A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury.
Cassatt DR, Gorovets A, Karimi-Shah B, Roberts R, Price PW, Satyamitra MM, Todd N, Wang SJ, Marzella L.
Cassatt DR, et al.
Radiat Res. 2022 Apr 1;197(4):415-433. doi: 10.1667/RADE-21-00127.1.
Radiat Res. 2022.
PMID: 34342637
Free PMC article.
Item in Clipboard
Cite
Cite